These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
249 related articles for article (PubMed ID: 35351042)
21. LncRNA MCM3AP-AS1 promotes proliferation and invasion through regulating miR-211-5p/SPARC axis in papillary thyroid cancer. Liang M; Jia J; Chen L; Wei B; Guan Q; Ding Z; Yu J; Pang R; He G Endocrine; 2019 Aug; 65(2):318-326. PubMed ID: 31030335 [TBL] [Abstract][Full Text] [Related]
22. Long non-coding RNA nuclear enriched abundant transcript 1 (NEAT1) modulates inhibitor of DNA binding 1 (ID1) to facilitate papillary thyroid carcinoma development by sponging microRNA-524-5p. Liao G; Huang Z; Gan T; Wu C; Wang X; Li D Bioengineered; 2022 May; 13(5):13201-13212. PubMed ID: 35635748 [TBL] [Abstract][Full Text] [Related]
23. Deletion of Meng Q; Wang L; Lv Y; Wu J; Shi W Cancer Biother Radiopharm; 2021 Feb; 36(1):23-35. PubMed ID: 32319789 [No Abstract] [Full Text] [Related]
24. Long noncoding RNA CASC7 inhibits the proliferation and migration of papillary thyroid cancer cells by inhibiting miR-34a-5p. Sun W; Yin D J Physiol Sci; 2021 Mar; 71(1):9. PubMed ID: 33706708 [TBL] [Abstract][Full Text] [Related]
25. lncRNA RPL34-AS1 inhibits cell proliferation and invasion while promoting apoptosis by competitively binding miR-3663-3p/RGS4 in papillary thyroid cancer. Ji L; Fan X; Zhou F; Gu J; Deng X J Cell Physiol; 2020 Apr; 235(4):3669-3678. PubMed ID: 31587286 [TBL] [Abstract][Full Text] [Related]
26. Long non-coding RNA ASMTL-AS1 inhibits tumor growth and glycolysis by regulating the miR-93-3p/miR-660/FOXO1 axis in papillary thyroid carcinoma. Feng Z; Chen R; Huang N; Luo C Life Sci; 2020 Mar; 244():117298. PubMed ID: 31953163 [TBL] [Abstract][Full Text] [Related]
27. STAT3-induced upregulation of lncRNA ABHD11-AS1 promotes tumour progression in papillary thyroid carcinoma by regulating miR-1301-3p/STAT3 axis and PI3K/AKT signalling pathway. Wen J; Wang H; Dong T; Gan P; Fang H; Wu S; Li J; Zhang Y; Du R; Zhu Q Cell Prolif; 2019 Mar; 52(2):e12569. PubMed ID: 30657221 [TBL] [Abstract][Full Text] [Related]
28. CircRNA NRIP1 promotes papillary thyroid carcinoma progression by sponging mir-195-5p and modulating the P38 MAPK and JAK/STAT pathways. Li C; Zhu L; Fu L; Han M; Li Y; Meng Z; Qiu X Diagn Pathol; 2021 Oct; 16(1):93. PubMed ID: 34689819 [TBL] [Abstract][Full Text] [Related]
29. Silencing of long noncoding RNA RP11-476D10.1 enhances apoptosis and autophagy while inhibiting proliferation of papillary thyroid carcinoma cells via microRNA-138-5p-dependent inhibition of LRRK2. Zhao Y; Zhao L; Li J; Zhong L J Cell Physiol; 2019 Nov; 234(11):20980-20991. PubMed ID: 31102261 [TBL] [Abstract][Full Text] [Related]
30. LncRNA Nian R; Li W; Li X; Zhang J; Li W; Pan F; Cheng J; Jin X Arch Endocrinol Metab; 2023 Jan; 67(1):55-63. PubMed ID: 35929906 [TBL] [Abstract][Full Text] [Related]
31. LncRNA LINC00460 promotes the papillary thyroid cancer progression by regulating the LINC00460/miR-485-5p/Raf1 axis. Li G; Kong Q Biol Res; 2019 Dec; 52(1):61. PubMed ID: 31870440 [TBL] [Abstract][Full Text] [Related]
32. Long non-coding RNA MFSD4A-AS1 promotes lymphangiogenesis and lymphatic metastasis of papillary thyroid cancer. Liu X; Zhang C; Wang X; Cui C; Cui H; Zhu B; Chen A; Zhang L; Xin J; Fu Q; Dionigi G; Sun H Endocr Relat Cancer; 2023 Mar; 30(3):. PubMed ID: 36606578 [TBL] [Abstract][Full Text] [Related]
33. Long noncoding RNA PVT1 enhances the viability and invasion of papillary thyroid carcinoma cells by functioning as ceRNA of microRNA-30a through mediating expression of insulin like growth factor 1 receptor. Feng K; Liu Y; Xu LJ; Zhao LF; Jia CW; Xu MY Biomed Pharmacother; 2018 Aug; 104():686-698. PubMed ID: 29803929 [TBL] [Abstract][Full Text] [Related]
34. Knockdown of circPUM1 impedes cell growth, metastasis and glycolysis of papillary thyroid cancer via enhancing MAPK1 expression by serving as the sponge of miR-21-5p. Li Y; Qin J; He Z; Cui G; Zhang K; Wu B Genes Genomics; 2021 Feb; 43(2):141-150. PubMed ID: 33481227 [TBL] [Abstract][Full Text] [Related]
35. MiR-146b-5p Regulates the Expression of Long Noncoding RNA Peng Y; Fang X; Yao H; Zhang Y; Shi J Cancer Biother Radiopharm; 2021 Jun; 36(5):433-440. PubMed ID: 32343601 [No Abstract] [Full Text] [Related]
36. The DLG1-AS1/miR-497/YAP1 axis regulates papillary thyroid cancer progression. Huang Y; Zhang K; Li Y; Dai Y; Zhao H Aging (Albany NY); 2020 Nov; 12(22):23326-23336. PubMed ID: 33197895 [TBL] [Abstract][Full Text] [Related]
37. LncRNA RGMB-AS1 is activated by E2F1 and promotes cell proliferation and invasion in papillary thyroid carcinoma. Zhang Z; Li SY; Zhang LB Eur Rev Med Pharmacol Sci; 2018 Apr; 22(7):1979-1986. PubMed ID: 29687852 [TBL] [Abstract][Full Text] [Related]
38. MiR-192-5p inhibits proliferation, migration, and invasion in papillary thyroid carcinoma cells by regulation of SH3RF3. Fu S; Ma C; Tang X; Ma X; Jing G; Zhao N; Ran J Biosci Rep; 2021 Sep; 41(9):. PubMed ID: 34486645 [TBL] [Abstract][Full Text] [Related]
39. Myocardial infarction associated transcript (MIAT) promotes papillary thyroid cancer progression via sponging miR-212. Wang R; Zhao L; Ji L; Bai L; Wen Q Biomed Pharmacother; 2019 Oct; 118():109298. PubMed ID: 31404776 [TBL] [Abstract][Full Text] [Related]
40. A novel lncRNA MCM3AP-AS1 promotes the growth of hepatocellular carcinoma by targeting miR-194-5p/FOXA1 axis. Wang Y; Yang L; Chen T; Liu X; Guo Y; Zhu Q; Tong X; Yang W; Xu Q; Huang D; Tu K Mol Cancer; 2019 Feb; 18(1):28. PubMed ID: 30782188 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]